🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

China Kidney Patient Trials Network

Recruitingn/aAges 2 Years - anyAllGeorge (Beijing) Clinical Research Co. Ltd.
NCT05036850 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This is a prospective multi-centre, observational cohort study of incident and prevalent patients diagnosed with a kidney disease in China.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Documented diagnosis of primary kidney disease 2. Regular visits (at least 6 monthly) with a physician at a participating site 3. eGFR \> 15 ml/min/1.73 m2 4. ≥ 2 years of age 5. Willing and able to sign informed consent 6. Willing to be approached about participation in interventional research studies Exclusion Criteria: * 1\. Life-expectancy of less than 6 months
💊

What it tests

  • Not listed
📍

Where

1 site
George Clinical (Beijing)
Beijing, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy